Pregnant and breastfeeding women: A priority population for HIV viral load monitoring

Landon Myer and colleagues discuss viral load monitoring for pregnant HIV-positive women and those breastfeeding; ART treatments can suppress viral load and are key to preventing transmission to the child.

[1]  D. Havlir,et al.  Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda , 2017, Journal of acquired immune deficiency syndromes.

[2]  L. Myer,et al.  Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  P. Mugwaneza,et al.  Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study , 2016, PloS one.

[4]  M. Egger,et al.  Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Gallant,et al.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission. , 2016, The New England journal of medicine.

[6]  Jeffrey N. Martin,et al.  HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods , 2016, Journal of acquired immune deficiency syndromes.

[7]  Jeffrey W. Eaton,et al.  Sustainable HIV treatment in Africa through viral-load-informed differentiated care , 2015, Nature.

[8]  S. Clark,et al.  The impacts of maternal mortality and cause of death on children’s risk of dying in rural South Africa: evidence from a population based surveillance study (1992-2013) , 2015, Reproductive Health.

[9]  I. Jani,et al.  Reducing mortality in HIV-infected infants and achieving the 90–90–90 target through innovative diagnosis approaches , 2015, Journal of the International AIDS Society.

[10]  Connie Celum,et al.  HIV infection: epidemiology, pathogenesis, treatment, and prevention , 2014, The Lancet.

[11]  M. Cortina-Borja,et al.  Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011 , 2014, AIDS.

[12]  N. Ford,et al.  Viral Load Monitoring as a Tool to Reinforce Adherence: A Systematic Review , 2013, Journal of acquired immune deficiency syndromes.

[13]  I. Birdthistle,et al.  Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review , 2013, Journal of the International AIDS Society.

[14]  J. Stringer,et al.  Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis , 2012, AIDS.

[15]  R. Tubiana,et al.  Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.